📄Overview
SWR-CENTRAL-HOSP-STORES/SOUTH WESTERN RLY has invited limited tender bids for "HUMAN INSULIN OF RECOMBINANT DNA ORIGIN 30/70 100 IU PER ML INJECTION (30 PERCENT SOLUBLE INSULIN AND 70 PERCENT ISOPHAN......" at India — a Railway / Metro goods on a Goods basis, carrying an estimated value of about ₹84.63 L (derived from the EMD, as the department didn't publish it). Bids close on 24 June 2026. EMD is ₹1.69 L. Reference CH261001.
🗓️Timeline
Published
—
Submission opens
—
Submission closes
24 Jun 2026
Bid opening
—
📎Tender documents
Documents are mirrored from the source portal for reference. Live bidding and authoritative documents remain on the official portal.
📋Complete tender details
🏷️ Identification
Tender IDIREPS-CH261001
Reference No.CH261001
OrganisationSWR-CENTRAL-HOSP-STORES/SOUTH WESTERN RLY
Product categoryGoods & Services
💰 Commercials
Estimated value₹84.63 L
Form of contractGoods
EMD₹1,69,260
Tender feeNil
⚖️ Process & eligibility
Tender typeLimited Tender
CategoryGoods
Two-stage bidding—
Withdrawal allowed—
📍 Location & authority
LocationIndia
Inviting authoritySWR-CENTRAL-HOSP-STORES/SOUTH WESTERN RLY
❓Frequently asked questions
What is this tender for?
SWR-CENTRAL-HOSP-STORES/SOUTH WESTERN RLY floated this tender for "HUMAN INSULIN OF RECOMBINANT DNA ORIGIN 30/70 100 IU PER ML INJECTION (30 PERCENT SOLUBLE INSULIN AND 70 PERCENT ISOPHAN......" — Railway / Metro work, procured as a goods contract on a Goods basis.
What is the estimated value?
The value was not disclosed; based on the EMD it works out to about ₹84.63 L.
What are the EMD and tender fee?
EMD is ₹1.69 L; tender fee is nil.
When do bids close?
Bids close on 24 June 2026.